Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Experimento de PCR [undo]
  • Jure je nejevoljen in ne želi sodelovati pri igri. [undo]
  • Αφιερώνετε χρόνο για την εξοικείωση με τις βασικές λειτουργίες του tablet [undo]
  • To stabilize the DNA double helix structure, ensuring precise cleavage [undo]
  • Game Over [undo]
  • Turgente (en solución hipotónica) y flácida (en solución isotónica) [undo]
  • Nad igro je navdušen in z veseljem sodeluje. [undo]
  • 2.She should include some kind of physical activity in her daily routine [undo]
  • Pentru a asigura plierea și funcționarea corectă a endonucleazei de restricție, maximizând activitatea sa catalitică [undo]
  • Urina pacientului conține glucoză. [undo]
  • ΚΥΤΤΑΡΙΚΗ ΔΙΑΙΡΕΣΗ [undo]
  • Learning Point [undo]
  • new node [undo]
  • Răspunsul 2 [undo]
  • Καλείτε την ομάδα της Μονάδας Εντατικής Θεραπείας [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway